Last reviewed · How we verify
NCT04560062: CEAD
Contextualizing the Evidence for Action on Diabetes - Cohort
trial testing Spontaneous changes in diabetes-related health care in Diabetes Mellitus, Type 2 in 1,152 participants. Status unknown.
30 June 2022
Quick facts
| Lead sponsor | Universidad Miguel Hernandez de Elche |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 1,152 |
| Start date | 13 October 2020 |
| Primary completion | 30 June 2022 |
| Estimated completion | 30 June 2022 |
| Sites | 1 location across Ecuador |
Drugs / interventions tested
- Spontaneous changes in diabetes-related health care
Conditions studied
- Diabetes Mellitus, Type 2 — all drugs for Diabetes Mellitus, Type 2 →
Sponsor
Universidad Miguel Hernandez de Elche — full company profile →
Who can join
18 and older, any sex, with Diabetes Mellitus, Type 2. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This protocol reflects the second part of a larger mixed-methods study aimed at exploring the process by which global recommendations can be translated into context-specific, evidence-informed action for diabetes prevention in low-resource settings. Firstly, a retrospective cohort study will assess the current level of implementation of comprehensive diabetes care over a 24-month period (2019-2020), by describing healthcare received and health outcomes of a representative sample of diabetes patients currently accessing care in the study region. Focus groups prompted by the findings of the retrospective study will be used to inspire local innovations which will be evaluated through a prospective follow-up of the cohort.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Contextualizing Evidence for Action on Diabetes in Low-Resource Settings-Project CEAD Part-II, Strengthening the Health System: A Mixed-Methods Study Protocol.
Bernal-Soriano MC, Barrera-Guarderas F, Alonso-Jaquete A, Chilet-Rosell E, et al · · 2021 · cited 4× · PMID 33805911 · DOI 10.3390/ijerph18073391
Verify or expand the search:
- PubMed search for NCT04560062
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Diabetes Mellitus, Type 2
Currently open trials in the same condition.
- NCT07415954 — A Research Study Comparing How Well Different Doses of the Medicine NNC0662-0419 Lower Blood Sugar in People With Type 2 · Phase 2 · recruiting
- NCT07532863 — A Real-world Study to Investigate Cardiovascular Risk Profile Among Newly Diagnosed Type 2 Diabetes Mellitus (T2DM) Part · recruiting
- NCT07336329 — Continuous Glucose Monitoring in Non-Insulin Treated Type 2 Diabetes: Continuous vs. Periodic Use · NA · recruiting
- NCT07242469 — A Clinical Trial of MK-1403 in Participants With Type 2 Diabetes Mellitus (MK-1403-006) · Phase 1 · recruiting
- NCT07444203 — Transformative Research in Diabetic Nephropathy 2.0 · recruiting
Other Universidad Miguel Hernandez de Elche trials
Trials by the same sponsor.
- NCT07498569 — Effects of Percutaneous Electrical Stimulation in Patients With Chronic Supraspinatus Tendinopathy · NA · not yet recruiting
- NCT07237971 — Cocreating Action to Improve Rationality in the Health System · NA · recruiting
- NCT07146789 — Home-based Graded Repetitive Arm Supplementary Program for Quality of Life and Functional Upper Limb Recovery · NA · recruiting
- NCT06889389 — Effects of Education and Exercise on Pain, Psychosocial Factors, and Upper Limb Function in Non-specific Neck Pain. · NA · recruiting
- NCT07192835 — Effect of Fruit Elicitation With Melatonin on Human Health · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04560062 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidad Miguel Hernandez de Elche
- Last refreshed: 25 January 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04560062.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing